DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $281,049 | -12.9% | 22,647 | -1.9% | 0.01% | -16.7% |
| Q4 2023 | $322,774 | -5.5% | 23,088 | -0.2% | 0.01% | -14.3% |
| Q3 2023 | $341,705 | +10.9% | 23,135 | -3.1% | 0.01% | +16.7% |
| Q2 2023 | $308,000 | -15.6% | 23,865 | -35.8% | 0.01% | -20.0% |
| Q1 2023 | $365,000 | -11.0% | 37,191 | -3.4% | 0.02% | -6.2% |
| Q4 2022 | $410,000 | +23.1% | 38,511 | +20.7% | 0.02% | +14.3% |
| Q3 2022 | $333,000 | -41.6% | 31,913 | -29.5% | 0.01% | -39.1% |
| Q2 2022 | $570,000 | +11.8% | 45,290 | -3.7% | 0.02% | +35.3% |
| Q1 2022 | $510,000 | +722.6% | 47,025 | +229.8% | 0.02% | +750.0% |
| Q3 2020 | $62,000 | -64.4% | 14,258 | -27.3% | 0.00% | -71.4% |
| Q2 2020 | $174,000 | – | 19,618 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |